Imunon, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announced it will host an R&D Day for investors, analysts, and media ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE